This is a snippet of the transcript, sign up to read more.
I can only speak from my experience. We've been hired by insurance companies to conduct due diligence work, which is not too different from the litigation funding underwriting. As I mentioned, you're going to examine the merits, damages, and the litigation strategy. However, the risk profile is different. A funder is paid a percentage of the proceeds, whereas an insurance company is paid a premium associated with not having to pay out the policy. The underlying factors are very similar, but the outward risk profile is different. To my knowledge, most insurers do not handle these matters in-house, although some may be moving in that direction. However, I haven't seen it yet.
This is a snippet of the transcript, sign up to read more.
The deal terms vary. For instance, one might have an insurance policy, expecting to make $100 million in six years, with the policy covering 50 million. This is hypothetical, of course. Assuming they pay out, which is a separate question, that's like guaranteed money. They want to collateralize that against their legal fees, let's say 10 million. They need help to do that. They may even need to pay a premium, 13% of that.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research